| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/24/2010 | WO2010069124A1 Amide thiazole derivative, preparation method and uses thereof |
| 06/24/2010 | WO2010069073A1 Combination of photodynamic therapy and anti-vegf agents in the treatment of unwanted choroidal neovasculature |
| 06/24/2010 | WO2010069069A1 Cathepsin b inhibitors |
| 06/24/2010 | WO2010069054A1 Novel c-1analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation |
| 06/24/2010 | WO2010051127A9 Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors |
| 06/24/2010 | WO2010049709A3 Therapeutic compositions comprising phenolic acids for treating conditions related to inap proriate platelet aggregation |
| 06/24/2010 | WO2010049705A3 Therapeutic compositions comprising flavonoids |
| 06/24/2010 | WO2010048603A8 Materials and methods for sensitizing multidrug resistant cells |
| 06/24/2010 | WO2010046932A3 Extended release pharmaceutical composition of minocycline and process thereof |
| 06/24/2010 | WO2010043972A3 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury |
| 06/24/2010 | WO2010043444A3 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury |
| 06/24/2010 | WO2010042530A3 Nlrc5 as a target for immune therapy |
| 06/24/2010 | WO2010041277A3 Stable pharmaceutical compositions of montelukast or its salts or solvates or hydrates |
| 06/24/2010 | WO2010039885A3 Crystalline forms of dexlansoprazole |
| 06/24/2010 | WO2010039851A9 Peripheral opioid receptor antagonists and uses thereof |
| 06/24/2010 | WO2010038948A3 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders |
| 06/24/2010 | WO2010038086A3 P38 map kinase inhibitors |
| 06/24/2010 | WO2010038085A3 P38 map kinase inhibitors |
| 06/24/2010 | WO2010036977A3 Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions |
| 06/24/2010 | WO2010033451A3 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators |
| 06/24/2010 | WO2010032976A3 Composition for prevention or treatment of heart failure |
| 06/24/2010 | WO2010032974A3 Improved production method for adefovir dipivoxil |
| 06/24/2010 | WO2010032266A3 Novel single unit carbapenem aminoglycoside formulations |
| 06/24/2010 | WO2010032154A3 Gangliosides from the avian nervous system and their uses for the diagnosis and the treatment of proventricular dilatation disease |
| 06/24/2010 | WO2010031835A3 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
| 06/24/2010 | WO2010030582A3 Noscapine and noscapine analogs and their use in treating infectious diseases by tubulin binding inhibition |
| 06/24/2010 | WO2010028015A3 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| 06/24/2010 | WO2010026483A3 Conjugate of a chitin derivative with natural sweeteners for controlling ingested fats in humans and having sweetening properties |
| 06/24/2010 | WO2010026436A3 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders |
| 06/24/2010 | WO2010022201A3 Folinic acid derivatives for promoting bone growth |
| 06/24/2010 | WO2010021514A3 Pharmaceutical composition containing glutamine for treating atopic dermatitis |
| 06/24/2010 | WO2010019832A3 Amide-extended crosslinking compounds and methods for use thereof |
| 06/24/2010 | WO2010019511A3 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 06/24/2010 | WO2010018596A3 Stable injectable oil-in-water docetaxel nanoemulsion |
| 06/24/2010 | WO2010017433A3 Use of sucralose as a granulating agent |
| 06/24/2010 | WO2010011346A9 Rnai constructs and uses therof |
| 06/24/2010 | WO2010005958A3 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 06/24/2010 | WO2010004435A3 Ph specific solutions of sodium mycophenolic acid for the treatment of eye disorders |
| 06/24/2010 | WO2010002777A3 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives |
| 06/24/2010 | WO2010002454A3 Therapeutic combinations for use in neoplasia |
| 06/24/2010 | WO2009155527A3 Phosphatidylinositol 3 kinase inhibitors |
| 06/24/2010 | WO2009137085A3 Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
| 06/24/2010 | WO2009122187A3 Pharmaceutical composition |
| 06/24/2010 | WO2009101616A9 Novel conjugates for treating neurodegenerative diseases and disorders |
| 06/24/2010 | WO2009089401A3 Compositions comprising toll-like receptor or coreceptor antagonists and methods for treating or controlling ocular allergy using same |
| 06/24/2010 | WO2009074498A8 Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate |
| 06/24/2010 | WO2007095223A3 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 06/24/2010 | US20100162422 Novel therapeutic and diagnostic products and methods |
| 06/24/2010 | US20100162420 Gastric carcinoma gene znf312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same |
| 06/24/2010 | US20100161032 Biologically engineered stent |
| 06/24/2010 | US20100160656 7-phenyl-substituted tetracycline compounds |
| 06/24/2010 | US20100160620 N-pyrazole a2a receptor agonists |
| 06/24/2010 | US20100160457 Thickened Spreadable Warming Lubricant |
| 06/24/2010 | US20100160456 Propofol Solution for Anesthetic Use |
| 06/24/2010 | US20100160455 Vitamin d3 analogues for the prevention and treatment of bone disorders |
| 06/24/2010 | US20100160454 Use of 1,2-cyclohexanedimethanol, 1,4-cyclohexanedimethanol, or 2,2,4,4-tetramethyl-1,3-cyclobutanediol as microbiocides or to prevent biofilms in water, for example use in personal care applications, in fuels, or on moldings or composites |
| 06/24/2010 | US20100160453 High alcohol content foaming compositions |
| 06/24/2010 | US20100160450 Methods of reducing 15-f2t-isop levels in mammals |
| 06/24/2010 | US20100160448 Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury |
| 06/24/2010 | US20100160447 Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
| 06/24/2010 | US20100160446 3,4-dimethoxyphenethylamine modulators of l-type calcium channel |
| 06/24/2010 | US20100160444 Method to inhibit ischemia and reperfusion injury |
| 06/24/2010 | US20100160443 Compounds useful for treating neurological disorders |
| 06/24/2010 | US20100160442 Formulations for cancer treatment |
| 06/24/2010 | US20100160441 Novel compounds |
| 06/24/2010 | US20100160440 Intranasal pharmaceutical compositions comprising succinic acid and methods thereof |
| 06/24/2010 | US20100160439 Dermatological compositions comprising at least one retinoid compound, an anti-irritant compound and benzoyl peroxide |
| 06/24/2010 | US20100160438 Novel use of a nutraceutical composition in animal feed |
| 06/24/2010 | US20100160437 Topical composition comprising a cyclofructan, a carrier and a drug |
| 06/24/2010 | US20100160436 Stable gabapentin compositions |
| 06/24/2010 | US20100160435 Composition of n-3 fatty acids having high concentration of epa and/or dha and containing n-6 fatty acids |
| 06/24/2010 | US20100160433 Treatment of neurodegenerative and cardiovascular disorders |
| 06/24/2010 | US20100160432 Curative drug for neurodegenerative diseases |
| 06/24/2010 | US20100160431 Methods and Compositions for the Treatment of Viral Infections |
| 06/24/2010 | US20100160429 Anti-bacterial plant compositions |
| 06/24/2010 | US20100160428 Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits |
| 06/24/2010 | US20100160427 Method of treating vascular injuries induced by an excess of plasma lipids using combinations of vasoprotective agents |
| 06/24/2010 | US20100160426 Crystalline genistein sodium salt dihydrate |
| 06/24/2010 | US20100160425 Anti-allergic agent and beverage/food, preparation for external application or cosmetic comprising the agent |
| 06/24/2010 | US20100160424 Renin inhibitors |
| 06/24/2010 | US20100160423 Small molecule antagonists of bacterial quorum-sensing receptors |
| 06/24/2010 | US20100160421 Influenza vaccines |
| 06/24/2010 | US20100160420 Novel simian t-cell lymphotropic virus |
| 06/24/2010 | US20100160419 Compositions and Methods for Vaccinating Against HSV-2 |
| 06/24/2010 | US20100160418 Compositions and Methods for Vaccinating Against HSV-2 |
| 06/24/2010 | US20100160417 Chromosome Therapy |
| 06/24/2010 | US20100160416 Use of pol iii promoters for controlled expression of therapeutic proteins |
| 06/24/2010 | US20100160415 Compositions and methods for treatment of autoimmune disease |
| 06/24/2010 | US20100160414 Treating Picornavirus Infection by Targeting MicroRNA miR-141 |
| 06/24/2010 | US20100160413 Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
| 06/24/2010 | US20100160412 Methods of modulating metabolic memory |
| 06/24/2010 | US20100160411 Benzoxathiine and benzoxathiole derivatives and uses thereof |
| 06/24/2010 | US20100160410 Use of pentadienoic acid derivatives for the treatment of hyperuricemia |
| 06/24/2010 | US20100160409 Highly Branched Reagents For Modifying Biopharmaceuticals, Their Preparation And Use |
| 06/24/2010 | US20100160408 Vildagliptin for treating general peripheral neuropathies |
| 06/24/2010 | US20100160407 Therapeutic substituted cyclic lactams |
| 06/24/2010 | US20100160406 Histamine h3 receptor agents, preparation and therapeutic uses |
| 06/24/2010 | US20100160405 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 06/24/2010 | US20100160404 New crystalline forms of perindopril erbumine |
| 06/24/2010 | US20100160403 Hcv ns3 protease inhibitors |